2015
$76M
from 12 investors over 12 rounds
BlackThorn Therapeutics raised $76M on June 13, 2019
Investors: Premier Partners, Polaris Partners, Biomatics Capital, GV, ARCH Venture Partners, Scripps, Vertex Ventures HC and Mercury Fund
BlackThorn Therapeutics raised $8M on June 20, 2017
Investors: National Institute of Neurological Disorders and Stroke (NINDS)
BlackThorn Therapeutics raised $14M on January 5, 2017
Investors: GV and Biomatics Capital
BlackThorn Therapeutics raised $40M on October 20, 2016
Investors: ARCH Venture Partners